secwatch / observer
8-K filed February 28, 2023, 6:59 PM ET ticker CME CIK 0001156375
leadership confidence high sentiment neutral materiality 0.55

CME Group CFO John Pietrowicz to retire April 1; Lynne Fitzpatrick named successor

CME GROUP INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lynne Fitzpatrick

Chief Financial Officer
CME · CME GROUP INC.
Effective
2023-04-01
Filed
February 28, 2023, 6:59 PM ET
Mr. Pietrowicz will retire from his position as Chief Financial Officer and Ms. Fitzpatrick will assume the role effective as of April 1, 2023.
Departed

John W. Pietrowicz

Chief Financial Officer
CME · CME GROUP INC.
Effective
2023-04-01
Successor
Lynne Fitzpatrick
Filed
February 28, 2023, 6:59 PM ET
Mr. Pietrowicz will retire from his position as Chief Financial Officer and Ms. Fitzpatrick will assume the role effective as of April 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lynne Fitzpatrick was appointed as Chief Financial Officer at CME GROUP INC..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Mr. Pietrowicz will retire from his position as Chief Financial Officer and Ms. Fitzpatrick will assume the role effective as of April 1, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

John W. Pietrowicz departed as Chief Financial Officer at CME GROUP INC..

Action
retire
Role
Chief Financial Officer
Exact text from the filing
Mr. Pietrowicz will retire from his position as Chief Financial Officer and Ms. Fitzpatrick will assume the role effective as of April 1, 2023.
View on SEC.gov

CME GROUP INC. filing history →

Source: SEC EDGAR
accession 0001193125-23-054102
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.